Table 3.

(A,B). Changes in IBAT and IWAT gene expression following 4V infusions of OT or vehicle in female sham or IBAT denervated DIO rats. (A), Changes in IBAT mRNA expression 4V infusions of OT or vehicle in female sham or IBAT denervated DIO rats; (B), Changes in IWAT mRNA expression 4V infusions of OT or vehicle in female sham or IBAT denervated DIO rats. Shared letters are not significantly different from one another. Data are expressed as mean ± SEM (N = 7–8/group).

Table 3A. Changes in IBAT mRNA Expression Following Chronic 4V Infusions of OT or Vehicle in Female HFD-Fed Rats
4V Treatment	Vehicle	OT
	Sham	Sham
IBAT
Adrb1	1.0 ± 0.4 a	1.5 ± 0.4 a
Adrb3	1.0 ± 0.3 a	1.9 ± 0.3 a
Ucp1	1.0 ± 0.3 a	1.2 ± 0.2 a
Cidea	1.0 ± 0.3 a	1.3 ± 0.3 a
Dio2	1.0 ± 0.4 a	0.3 ± 0.2 a
Gpr120	1.0 ± 0.5 a	1.2 ± 0.4 a
Prdm16	1.0 ± 0.3 a	1.2 ± 0.2 a
Ppargc1a	1.0 ± 0.3 a	1.2 ± 0.2 a
Table 3B. Changes in IWAT mRNA Expression Following Chronic 4V Infusions of OT or Vehicle in Female HFD-Fed Rats
4V Treatment	Vehicle	OT
	Sham	Sham
IWAT
Adrb1	1.0 ± 0.2 a	2.7 ± 0.6 b
Adrb3	1.0 ± 0.4 a	2.0 ± 0.5 a
Ucp1	1.0 ± 0.3 a	0.5 ± 0.1 a
Cidea	1.0 ± 0.2 a	2.8 ± 0.5 b
DIio2	1.0 ± 0.3 a	1.0 ± 0.2 a
Gpr120	1.0 ± 0.3 a	2.0 ± 0.4 a
Prdm16	1.0 ± 0.1 a	1.6 ± 0.3 a
Ppargc1a	1.0 ± 0.2 a	0.9 ± 0.1 a

IBAT was collected following a 4-h fast. Different letters denote significant differences between treatments. Shared letters are not significantly different from one another. N = 7–8/group. IWAT was collected following a 4-h fast. Different letters denote significant differences between treatments. Shared letters are not significantly different from one another.